Mitochondria as Therapeutic Targets in Transplantation
- PMID: 32952044
- DOI: 10.1016/j.molmed.2020.08.001
Mitochondria as Therapeutic Targets in Transplantation
Erratum in
-
Correction to: Mitochondria as Therapeutic Targets in Transplantation: (Trends in Molecular Medicine 27:2 p:185-198, 2021).Trends Mol Med. 2021 May;27(5):512. doi: 10.1016/j.molmed.2021.02.001. Epub 2021 Feb 27. Trends Mol Med. 2021. PMID: 33653669 No abstract available.
Abstract
Advances in surgical procedures, technology, and immune suppression have transformed organ transplantation. However, the metabolic changes that occur during organ retrieval, storage, and implantation have been relatively neglected since the developments many decades ago of cold storage organ preservation solutions. In this review we discuss how the metabolic changes that occur within the organ during transplantation, particularly those associated with mitochondria, may contribute to the outcome. We show how a better understanding of these processes can lead to changes in surgical practice and the development of new drug classes to improve the function and longevity of transplanted grafts, while increasing the pool of organs available for transplantation.
Keywords: ischemia–reperfusion injury; metabolism.; mitochondria; transplantation.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical